6196.TW
Marketech International Corp.
TaiwanTWDEQUITY
Technology
DELAYED
Last price
489.00
▼ 7.00 (1.41%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
496.00
Prev close
496.00
Day high
498.50
Day low
483.50
Volume
1.18M
Market cap
$108.07B
P/E (TTM)
22.73
52W range
218.50 – 607.00
Day trading desk
Gap from prior close
0.00%
Prior close 496.00
VWAP
489.59
-0.12% from price
Relative volume
0.57×
Quiet session
Session range
3.10%
483.50 – 498.50
Position in range
37%
Mid range
ATR (14D)
21.57
4.41% of price
Prior day high
509.00
PDH
Prior day low
491.00
PDL
Bid / ask spread
—
Quote not published
Session volume
1.07M
Avg 1.87M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.82%
-2.5%
1M
-9.67%
-13.4%
3M
+0.93%
-2.2%
6M
+85.09%
+74.0%
YTD
+78.36%
+66.1%
1Y
+123.97%
+104.0%
3Y
+263.33%
+189.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 6196.TW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
125.37M
Total on file
Fundamentals
Market cap$108.07B
Enterprise value$98.01B
Revenue (TTM)$61.62B
Gross profit$7.60B
EBITDA$4.28B
Net income$4.86B
EPS (TTM)$21.58
Free cash flow$9.40B
Total cash$16.13B
Total debt$5.83B
Book value / share$81.05
Shares outstanding220.33M
Float100.91M
Short % of float—
Dividend yield1.31%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E22.73
Forward P/E17.42
PEG ratio—
Price / sales—
Price / book6.05
EV / revenue1.59
EV / EBITDA22.89
Gross margin12.33%
Operating margin8.92%
Profit margin7.89%
Return on equity31.78%
Return on assets4.49%
Debt / equity32.30
Current ratio1.23
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $51.57B | $60.68B | $56.28B | $50.37B | -15.0% |
| Operating revenue | $51.57B | $60.68B | $56.28B | $50.37B | -15.0% |
| Cost of revenue | $45.92B | $55.40B | $51.03B | $44.98B | -17.1% |
| Gross profit | $5.65B | $5.28B | $5.25B | $5.39B | +7.1% |
| Research & development | $288.49M | $277.65M | $284.76M | $277.87M | +3.9% |
| Selling, general & admin | $3.06B | $2.51B | $2.36B | $2.07B | +21.8% |
| Total operating expense | $3.35B | $2.79B | $2.65B | $2.34B | +20.1% |
| Operating income | $2.30B | $2.48B | $2.60B | $3.04B | -7.4% |
| Net interest income | -$108.71M | -$365.46M | -$247.63M | -$70.73M | +70.3% |
| Pre-tax income | $3.88B | $2.64B | $2.84B | $3.00B | +47.3% |
| Tax provision | $718.74M | $880.12M | $735.93M | $842.15M | -18.3% |
| Net income | $3.24B | $1.80B | $2.16B | $2.22B | +79.8% |
| Net income to common | $3.24B | $1.80B | $2.16B | $2.22B | +79.8% |
| Basic EPS | 15.50 | 8.94 | 10.96 | 11.36 | +73.4% |
| Diluted EPS | 14.66 | 8.27 | 10.47 | 10.89 | +77.3% |
| EBIT | $4.09B | $3.10B | $3.18B | $3.09B | +31.7% |
| EBITDA | $4.89B | $4.11B | $3.85B | $3.55B | +18.9% |
| Basic shares | 208.78M | 201.31M | 197.22M | 197.22M | +3.7% |
| Diluted shares | 222.01M | 221.72M | 208.37M | 208.37M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $13.01B | $11.44B | $7.21B | $6.48B | +13.7% |
| Cash & short-term investments | $13.14B | $11.51B | $7.37B | $6.59B | +14.1% |
| Accounts receivable | $8.54B | $6.73B | $8.59B | $6.32B | +26.9% |
| Inventory | $10.23B | $7.81B | $7.32B | $6.27B | +30.9% |
| Total current assets | $46.71B | $37.95B | $39.46B | $30.10B | +23.1% |
| Property, plant & equipment | $6.18B | $5.91B | $4.90B | $4.07B | +4.5% |
| Goodwill & intangibles | $99.45M | $97.14M | $98.63M | $109.19M | +2.4% |
| Total assets | $57.45B | $46.66B | $46.70B | $35.46B | +23.1% |
| Total current liabilities | $37.78B | $29.55B | $30.22B | $23.95B | +27.9% |
| Current debt | $5.93B | $7.83B | $11.43B | $8.16B | -24.3% |
| Long-term debt | $1.40B | $2.65B | $2.61B | $200.00M | -46.9% |
| Total debt | $9.67B | $13.13B | $16.65B | $9.99B | -26.3% |
| Total liabilities | $41.26B | $34.63B | $35.46B | $25.97B | +19.1% |
| Retained earnings | $7.71B | $5.72B | $5.37B | $4.46B | +34.8% |
| Shareholder equity | $16.07B | $11.90B | $11.14B | $9.36B | +35.0% |
| Working capital | $8.93B | $8.40B | $9.24B | $6.15B | +6.3% |
| Net tangible assets | $15.97B | $11.80B | $11.04B | $9.25B | +35.3% |
| Shares issued | 218.59M | 201.32M | 201.32M | 195.03M | +8.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $3.88B | $2.64B | $2.84B | $3.00B | +47.3% |
| Depreciation & amortisation | $804.23M | $1.01B | $670.02M | $453.32M | -20.3% |
| Stock-based compensation | $20.98M | $0 | $0 | $121.00K | — |
| Change in working capital | $3.69B | $8.15B | -$6.54B | -$1.75B | -54.8% |
| Operating cash flow | $5.66B | $10.92B | -$4.17B | $1.40B | -48.1% |
| Capital expenditure | -$1.25B | -$1.39B | -$266.17M | -$406.24M | +10.4% |
| Investing cash flow | -$1.14B | -$1.35B | -$558.78M | -$18.10M | +15.3% |
| Dividends paid | -$1.21B | -$1.21B | -$1.11B | -$867.40M | -0.0% |
| Financing cash flow | -$2.65B | -$5.69B | $5.56B | $791.59M | +53.3% |
| Free cash flow | $4.41B | $9.53B | -$4.44B | $988.83M | -53.7% |
| End cash position | $13.01B | $11.44B | $7.21B | $6.48B | +13.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $14.31B | $14.64B | $11.47B | $12.20B | $13.26B | -2.3% |
| Operating revenue | $14.31B | $14.64B | $11.47B | $12.20B | $13.26B | -2.3% |
| Cost of revenue | $12.37B | $13.10B | $10.21B | $10.81B | $11.80B | -5.6% |
| Gross profit | $1.94B | $1.54B | $1.26B | $1.38B | $1.46B | +25.7% |
| Research & development | $65.39M | $75.45M | $79.35M | $62.94M | $70.75M | -13.3% |
| Selling, general & admin | $798.49M | $814.65M | $809.09M | $707.53M | $732.41M | -2.0% |
| Total operating expense | $863.88M | $890.11M | $888.44M | $770.48M | $803.15M | -2.9% |
| Operating income | $1.08B | $654.56M | $372.72M | $614.50M | $657.83M | +64.6% |
| Net interest income | -$21.26M | -$27.58M | -$28.42M | -$8.78M | -$43.93M | +22.9% |
| Pre-tax income | $1.39B | $902.77M | $1.34B | $451.43M | $1.19B | +53.6% |
| Tax provision | $277.19M | $149.01M | $176.83M | $80.47M | $312.43M | +86.0% |
| Net income | $1.11B | $768.00M | $1.18B | $396.39M | $888.68M | +44.9% |
| Net income to common | $1.11B | $768.00M | $1.18B | $396.39M | $888.68M | +44.9% |
| Basic EPS | 5.08 | — | 5.57 | 1.95 | 4.41 | — |
| Diluted EPS | 5.03 | — | 5.49 | 1.85 | 4.05 | — |
| EBIT | $1.42B | $956.22M | $1.38B | $498.28M | $1.25B | +48.6% |
| EBITDA | $1.60B | $1.15B | $1.58B | $699.68M | $1.47B | +39.7% |
| Basic shares | 219.04M | — | 212.34M | 203.28M | 201.50M | — |
| Diluted shares | 219.04M | — | 215.44M | 214.27M | 221.54M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.67B | $13.01B | $9.20B | $7.76B | $10.10B | -2.6% |
| Cash & short-term investments | $12.81B | $13.14B | $9.29B | $7.84B | $10.16B | -2.5% |
| Accounts receivable | $7.75B | $8.54B | $10.27B | $7.57B | $7.18B | -9.2% |
| Inventory | $11.75B | $10.23B | $9.17B | $8.38B | $8.41B | +14.9% |
| Total current assets | $46.34B | $46.71B | $41.70B | $36.13B | $37.94B | -0.8% |
| Property, plant & equipment | $6.46B | $6.18B | $5.93B | $6.00B | $6.06B | +4.5% |
| Goodwill & intangibles | $97.56M | $99.45M | $96.04M | $95.79M | $98.03M | -1.9% |
| Total assets | $57.38B | $57.45B | $51.97B | $45.37B | $46.89B | -0.1% |
| Total current liabilities | $36.02B | $37.78B | $33.48B | $29.73B | $27.86B | -4.7% |
| Current debt | $3.83B | $5.93B | $5.30B | $6.88B | $5.29B | -35.4% |
| Long-term debt | $1.40B | $1.40B | $1.11B | $1.11B | $3.44B | -0.1% |
| Total debt | $7.81B | $9.67B | $8.79B | $10.41B | $11.31B | -19.2% |
| Total liabilities | $39.73B | $41.26B | $36.72B | $33.12B | $33.76B | -3.7% |
| Retained earnings | $8.82B | $7.71B | $6.93B | $5.75B | $6.61B | +14.4% |
| Shareholder equity | $17.47B | $16.07B | $15.12B | $12.11B | $12.96B | +8.7% |
| Working capital | $10.31B | $8.93B | $8.21B | $6.39B | $10.08B | +15.5% |
| Net tangible assets | $17.37B | $15.97B | $15.03B | $12.01B | $12.87B | +8.8% |
| Shares issued | 220.33M | 218.59M | 218.00M | 204.56M | 202.20M | +0.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $1.39B | $902.77M | $1.34B | $451.43M | $1.19B | — | +53.6% |
| Depreciation & amortisation | $178.87M | $188.92M | $196.44M | $201.40M | $217.47M | — | -5.3% |
| Stock-based compensation | $3.49M | $5.68M | $7.69M | $7.61M | $0 | — | -38.6% |
| Change in working capital | $151.98M | $3.02B | $2.13B | -$999.35M | -$469.66M | — | -95.0% |
| Operating cash flow | $1.41B | $3.72B | $2.56B | -$1.10B | $486.61M | — | -62.1% |
| Capital expenditure | -$127.04M | -$418.49M | -$249.65M | -$235.76M | -$342.95M | — | +69.6% |
| Investing cash flow | -$164.79M | -$457.80M | -$330.32M | $13.80M | -$368.36M | — | +64.0% |
| Dividends paid | — | $0 | — | — | — | $0 | — |
| Financing cash flow | -$1.68B | $428.06M | -$743.87M | -$790.37M | -$1.55B | — | -492.2% |
| Free cash flow | $1.28B | $3.30B | $2.31B | -$1.34B | $143.66M | — | -61.1% |
| End cash position | $12.67B | $13.01B | $9.20B | $7.76B | $10.10B | — | -2.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 5.92 | 8.15 | +37.7% |
| Mar 2026 | 3.61 | 5.08 | +40.7% |
| Dec 2025 | 2.61 | 3.45 | +32.2% |
| Sep 2025 | 3.66 | 5.57 | +52.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 7.63 | 2 | $21.78B | +90.0% |
| Next quarter | 7.46 | 2 | $22.57B | +54.2% |
| Current year | 24.47 | 3 | $75.39B | +46.2% |
| Next year | 28.15 | 3 | $87.04B | +15.5% |
Analyst targets & ownership
Mean target$562.00
High target$666.00
Low target$370.00
Implied upside14.93%
Analyst count3
ConsensusNONE
Strong buy / Buy0 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders56.88%
Held by institutions11.40%
Institutions holding62
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
503.75
-2.93% from price
SMA 20
493.48
-0.60% from price
SMA 50
529.27
-7.33% from price
SMA 100
469.09
+4.24% from price
SMA 200
367.35
+33.52% from price
EMA 12
500.94
-2.38% from price
EMA 26
506.87
-3.53% from price
EMA 50
503.54
-2.89% from price
RSI (14)
44.1
Neutral
MACD (12,26,9)
-5.93
Hist 0.67
ATR (14)
21.57
4.40% of price
Realised vol 30D
59.2%
Annualised
Bollinger upper
535.24
20, 2σ
Bollinger lower
451.71
20, 2σ
50 / 200 cross
Golden
529.27 vs 367.35
Trend bias
Above 200
+33.52%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.51
Less volatile than market
Correlation to SPY
0.13
Largely independent
Realised vol 30D
59.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-26.1%
Peak to trough
Max drawdown 5Y
-47.4%
Peak to trough
ATR 14
21.57
4.40% of price
Beta (reported)
—
5Y monthly, from filing
Dividends & splits
Forward rate$6.45 / yr
Forward yield1.31%
5-year avg yield4.42%
Payout ratio57.19%
Ex-dividend dateJun 24, 2026
Next pay date—
Last split1.1:1
Split dateSep 14, 2009
Headlines
What Does a D-Wave Quantum Insider's Sale of 23,850 Shares Mean for Investors?
Motley Fool · 16m ago
Thousands expected at Sweden climate demo as election looms
AFP · 17m ago
Cowboys vs. Cardinals highlights Preseason Week 2
NFL Highlights · 21m ago
Which Energy ETF Is a Better Buy: Broad Vanguard Fund or Concentrated XLE?
Motley Fool · 23m ago
Joe Milton III's best plays from 3-TD game vs. Cardinals Preseason Week 2
NFL Highlights · 32m ago
BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data – What's Changed
Simply Wall St. · 37m ago
Applied Industrial Technologies (AIT) Could Be 15% Undervalued After Earnings And 2027 Guidance
Simply Wall St. · 37m ago
Everpure (P) Lands Supply Agreement With A Second Top Five Hyperscaler
Simply Wall St. · 37m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.